241 related articles for article (PubMed ID: 34856983)
1. Regular use of proton-pump inhibitors and risk of stroke: a population-based cohort study and meta-analysis of randomized-controlled trials.
Yang M; He Q; Gao F; Nirantharakumar K; Veenith T; Qin X; Page AT; Wong MCS; Huang J; Kuo ZC; Xia B; Zhang C; He Y; Meng W; Yuan J; Pan Y
BMC Med; 2021 Dec; 19(1):316. PubMed ID: 34856983
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Association between regular proton pump inhibitors use and cardiovascular outcomes: A large prospective cohort study.
Li ZH; Zhong WF; Qiu CS; Yang P; Song WQ; Shen D; Zhang XR; Liu D; Chen YJ; Chen PL; Huang QM; Chen Q; Wang XM; Chung VCH; Gao X; Kraus VB; Liu SD; Mao C
Int J Cardiol; 2024 Jan; 395():131567. PubMed ID: 37935336
[TBL] [Abstract][Full Text] [Related]
4. Regular use of proton pump inhibitors and risk of type 2 diabetes: results from three prospective cohort studies.
Yuan J; He Q; Nguyen LH; Wong MCS; Huang J; Yu Y; Xia B; Tang Y; He Y; Zhang C
Gut; 2021 Jun; 70(6):1070-1077. PubMed ID: 32989021
[TBL] [Abstract][Full Text] [Related]
5. Comparison of different regimens of proton pump inhibitors for acute peptic ulcer bleeding.
Neumann I; Letelier LM; Rada G; Claro JC; Martin J; Howden CW; Yuan Y; Leontiadis GI
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD007999. PubMed ID: 23760821
[TBL] [Abstract][Full Text] [Related]
6. Proton Pump Inhibitor Use and the Risk of Cardiovascular Complications and Death in Older Adults with Diabetes: A Population-Based Cohort Study.
Foresta A; Fernandez LO; Torrigiani G; Schena S; Roncaglioni MC; Nobili A; Tettamanti M; Franchi C; Fortino I; Succurro E; Sesti G; Baviera M
Drugs Aging; 2024 Mar; 41(3):239-249. PubMed ID: 38367169
[TBL] [Abstract][Full Text] [Related]
7. Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions.
Song H; Zhu J; Lu D
Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010623. PubMed ID: 25464111
[TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitors for functional dyspepsia.
Pinto-Sanchez MI; Yuan Y; Hassan A; Bercik P; Moayyedi P
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011194. PubMed ID: 29161458
[TBL] [Abstract][Full Text] [Related]
9. Regular Use of Proton Pump Inhibitor and the Risk of Inflammatory Bowel Disease: Pooled Analysis of 3 Prospective Cohorts.
Xia B; Yang M; Nguyen LH; He Q; Zhen J; Yu Y; Di M; Qin X; Lu K; Kuo ZC; He Y; Zhang C; Meng W; Yuan J
Gastroenterology; 2021 Dec; 161(6):1842-1852.e10. PubMed ID: 34389338
[TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitors for functional dyspepsia.
Pinto-Sanchez MI; Yuan Y; Bercik P; Moayyedi P
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011194. PubMed ID: 28271513
[TBL] [Abstract][Full Text] [Related]
11. Association Between Regular Use of Gastric Acid Suppressants and Subsequent Risk of Cholelithiasis: A Prospective Cohort Study of 0.47 Million Participants.
Yang M; Xia B; Lu Y; He Q; Lin Y; Yue P; Bai B; Dong C; Meng W; Qi J; Yuan J
Front Pharmacol; 2021; 12():813587. PubMed ID: 35153765
[No Abstract] [Full Text] [Related]
12. No consistent evidence of differential cardiovascular risk amongst proton-pump inhibitors when used with clopidogrel: meta-analysis.
Kwok CS; Jeevanantham V; Dawn B; Loke YK
Int J Cardiol; 2013 Aug; 167(3):965-74. PubMed ID: 22464478
[TBL] [Abstract][Full Text] [Related]
13. Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies.
Poly TN; Islam MM; Yang HC; Wu CC; Li YJ
Osteoporos Int; 2019 Jan; 30(1):103-114. PubMed ID: 30539272
[TBL] [Abstract][Full Text] [Related]
14. Conflicting results between randomized trials and observational studies on the impact of proton pump inhibitors on cardiovascular events when coadministered with dual antiplatelet therapy: systematic review.
Melloni C; Washam JB; Jones WS; Halim SA; Hasselblad V; Mayer SB; Heidenfelder BL; Dolor RJ
Circ Cardiovasc Qual Outcomes; 2015 Jan; 8(1):47-55. PubMed ID: 25587094
[TBL] [Abstract][Full Text] [Related]
15. Deprescribing versus continuation of chronic proton pump inhibitor use in adults.
Boghossian TA; Rashid FJ; Thompson W; Welch V; Moayyedi P; Rojas-Fernandez C; Pottie K; Farrell B
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011969. PubMed ID: 28301676
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological interventions for prevention and treatment of upper gastrointestinal bleeding in newborn infants.
Green DS; Abdel-Latif ME; Jones LJ; Lui K; Osborn DA
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD011785. PubMed ID: 31265739
[TBL] [Abstract][Full Text] [Related]
17. Do proton pump inhibitors increase mortality? A systematic review and in-depth analysis of the evidence.
Ben-Eltriki M; Green CJ; Maclure M; Musini V; Bassett KL; Wright JM
Pharmacol Res Perspect; 2020 Oct; 8(5):e00651. PubMed ID: 32996701
[TBL] [Abstract][Full Text] [Related]
18. Clopidogrel-Proton Pump Inhibitor Drug-Drug Interaction and Risk of Adverse Clinical Outcomes Among PCI-Treated ACS Patients: A Meta-analysis.
Serbin MA; Guzauskas GF; Veenstra DL
J Manag Care Spec Pharm; 2016 Aug; 22(8):939-47. PubMed ID: 27459657
[TBL] [Abstract][Full Text] [Related]
19. Long-term use of proton pump inhibitors, dose-response relationship and associated risk of ischemic stroke and myocardial infarction.
Sehested TSG; Gerds TA; Fosbøl EL; Hansen PW; Charlot MG; Carlson N; Hlatky MA; Torp-Pedersen C; Gislason GH
J Intern Med; 2018 Mar; 283(3):268-281. PubMed ID: 29024109
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
